Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/29/2007CA2619068A1 Imidazole compounds for the treatment of neurological disorders
03/29/2007CA2615897A1 Compounds and methods for treatment of amyloid-beta-peptide related disorders
03/29/2007CA2613521A1 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
03/28/2007EP1767638A2 Mutation associated with epilepsy
03/28/2007EP1767637A1 Mutation associated with epilepsy
03/28/2007EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
03/28/2007EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer
03/28/2007EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor
03/28/2007EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
03/28/2007EP1767537A1 Pyrimidine compounds for the treatment of inflammatory disorders
03/28/2007EP1767536A1 Quinolone carboxylic acid derivatives, thereof preparation and usage
03/28/2007EP1767535A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
03/28/2007EP1767534A1 Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
03/28/2007EP1767533A1 N-{(2-(2,6-dioxo(3-piperidyl)-1,3-dioxo-2,3-dihydro-1H-isoindolin-4-yl)methyl}cyclopropylcarboxamide as TNF inhibitor
03/28/2007EP1767531A1 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof
03/28/2007EP1767526A1 Novel arylamidine derivative, salt thereof, and antifungal containing these
03/28/2007EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists
03/28/2007EP1767246A1 Composition for moistening oral cavity
03/28/2007EP1767223A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
03/28/2007EP1767222A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases
03/28/2007EP1767219A2 Stable injectable diclofenac compositions
03/28/2007EP1767218A1 Antiinflammatory and analgesic preparation for external use
03/28/2007EP1767217A1 Agent for promoting the recovery from dysfunction after the onset of central neurological disease
03/28/2007EP1767216A1 Drug having regulatory cell ligand contained in liposome
03/28/2007EP1767215A1 Isoflavones against radiation-induced mortality
03/28/2007EP1767211A1 Pharmaceutical agent containing hyaluronan as an active ingredient
03/28/2007EP1767210A1 The medical use of paeoniflorin
03/28/2007EP1767209A1 Neuroprotective drug
03/28/2007EP1767208A1 Remedy for hyperactive bladder
03/28/2007EP1767207A2 Solid Oral Dosage Forms
03/28/2007EP1767206A2 Solid Oral Dosage Forms
03/28/2007EP1767205A1 Lipase inhibitors
03/28/2007EP1767204A1 Lipase inhibitors
03/28/2007EP1767203A1 Fat combustion accelerator
03/28/2007EP1767202A1 3,5,3'-Triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
03/28/2007EP1767201A1 Nutrient composition and composition for prevention/mitigation of digestive tract depression
03/28/2007EP1767200A1 Antiaging agent
03/28/2007EP1767199A2 Methods and compositions for treatment of cancer pain
03/28/2007EP1767198A1 Regulator of physiological function of ghrelin and use thereof
03/28/2007EP1767197A2 Treatment of Alzheimer's disease with inhibitors of cell cycle re-entry and progression
03/28/2007EP1767196A2 Highly efficient delivery of a large therapeutic mass aerosol
03/28/2007EP1767194A1 Process for the preparation of adsorbates of drospirenone
03/28/2007EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells
03/28/2007EP1766387A2 An innovative screening method for coronary heart disease and stroke
03/28/2007EP1766094A2 Influenza virus vaccine composition and method of use
03/28/2007EP1766068A2 Egfr mutations
03/28/2007EP1766052A1 Chimeric gapped oligomeric compositions
03/28/2007EP1766044A2 Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
03/28/2007EP1766035A1 Lipid encapsulated interfering rna
03/28/2007EP1766013A2 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases
03/28/2007EP1766010A1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
03/28/2007EP1766009A2 Treatment of neurodegenerative disease through intracranial delivery of sirna
03/28/2007EP1765874A1 Modified pectins, compositions and methods related thereto
03/28/2007EP1765850A1 Substituted propane phosphinic acid derivatives
03/28/2007EP1765844A2 Purine nucleotide derivatives
03/28/2007EP1765842A1 D-xylopyranosyl-substituted phenyls, medicaments containing said compounds, the use thereof, and methods for producing the same
03/28/2007EP1765832A1 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
03/28/2007EP1765830A1 Mitotic kinesin inhibitors
03/28/2007EP1765829A1 Tricyclic compounds and their use as mglur1 antagonists
03/28/2007EP1765825A1 Condensed triazoles and indazoles useful in treating citokines mediated diseases and other diseases
03/28/2007EP1765823A1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/28/2007EP1765821A2 Gram-positive carbapenem antibacterials and processes for their preparation
03/28/2007EP1765819A1 Azaindoles useful as inhibitors of protein kinases
03/28/2007EP1765818A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use
03/28/2007EP1765817A1 Thiazolinone unsubstituted quinolines
03/28/2007EP1765816A1 Substituted 1-propiolylpiperazines having an affinity for the mglur5 receptor in order to treat painful conditions
03/28/2007EP1765815A2 New compounds useful for treating cns disorders
03/28/2007EP1765814A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists
03/28/2007EP1765813A1 Substituted indazoles, compositions containing same, preparation and use
03/28/2007EP1765811A2 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents
03/28/2007EP1765810A1 2,4-diaminoquinazolines for spinal muscular atrophy
03/28/2007EP1765809A1 Xanthine derivatives useful as muscarinic receptor antagonists
03/28/2007EP1765808A1 Bisarylurea derivatives useful for inhibiting chk1
03/28/2007EP1765807A1 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation
03/28/2007EP1765806A1 New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
03/28/2007EP1765805A2 Cgrp receptor antagonists
03/28/2007EP1765804A2 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
03/28/2007EP1765803A1 Quaternary salt ccr2 antagonists
03/28/2007EP1765797A1 Phenothiazine derivatives and their method of use
03/28/2007EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds
03/28/2007EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/28/2007EP1765793A1 Cetp inhibitors
03/28/2007EP1765792A1 Sulfamic acid ester compounds useful in the inhibition of steroid sulphatase activity and aromatase activity
03/28/2007EP1765791A1 Pyrimidine derivatives useful as inhibitors of pkc-theta
03/28/2007EP1765790A1 Azine-carboxamides as anti-cancer agent
03/28/2007EP1765789A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
03/28/2007EP1765788A2 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases
03/28/2007EP1765786A2 An improved process for the preparation of oxcarbazepine and related intermediates
03/28/2007EP1765785A1 Prostaglandin analogs
03/28/2007EP1765784A2 Antibiotic cycloalkyltetrahydroquinoline derivatives
03/28/2007EP1765782A1 Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
03/28/2007EP1765781A2 Optically enhanced chiral ionic liquids
03/28/2007EP1765779A1 New substituted piperidines as modulators of dopamine neurotransmission
03/28/2007EP1765778A2 N-sulfonylcarboximidamide apoptosis promoters
03/28/2007EP1765776A1 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (gpcrs)
03/28/2007EP1765775A1 Indoles useful in the treatment of inflammation
03/28/2007EP1765769A1 Process for the preparation of nateglinide
03/28/2007EP1765768A1 Substituted acids for the treatment of respiratory diseases
03/28/2007EP1765765A1 Arylalkylamine vanadium (v) salts for the treatment and/or prevention of diabetes mellitus
03/28/2007EP1765760A1 Phenyl derivatives comprising an acetylene group
1 ... 3821 3822 3823 3824 3825 3826 3827 3828 3829 3830 3831 3832 3833 3834 3835 3836 3837 3838 3839 3840 3841 ... 7860